NMT Group PLC
16 November 2000
NMT GROUP PLC
UPDATE ON LEGAL PROCEDINGS RELATING TO ALLEGED
PATENT INFRINGEMENT
NMT Group PLC announces that the trial related to the claim by Medsafe
Technologies LLC and Syringe Development Partners LLC for alleged patent
infringement, which was scheduled for November 2000, has been rescheduled for
March 2001. The US District Court in Indiana has postponed the trial in order
to consider and rule on several motions, which remain pending.
The Company's position on this matter remains unchanged and the Directors
remain confident that these claims can be successfully defended and will have
no material impact on the business.
Enquiries:
NMT Group PLC
Tony Fletcher: 01506 445000
Financial Dynamics
David Yates: 0207831 3113
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.